MedPath

Fat Absorption and Metabolism After Roux-en-Y Gastric Bypass

Not Applicable
Completed
Conditions
Bariatric Surgery
Registration Number
NCT04859816
Lead Sponsor
Hvidovre University Hospital
Brief Summary

Using intravenous and oral administration of stable isotope tracers, we will investigate the importance of altered fat absorption and altered whole body fat metabolism for the reduced postprandial systemic TAG concentrations in non-diabetic patients in weight stable phase after RYGB.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Area under the curve of plasma triacylglycerol6 hours

During a high-fat liquid mixed meal test

Secondary Outcome Measures
NameTimeMethod
Recovery of oral stable triacylglycerol isotope tracer in feces4 days

An oral stable triacylglycerol isotope tracer will be administered during a high-fat liquid mixed meal test. Feces will be collected the following 4 days to determine the recovery of the tracer in feces.

Trial Locations

Locations (1)

Hvidovre Hospital

🇩🇰

Hvidovre, Denmark

Hvidovre Hospital
🇩🇰Hvidovre, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.